About this trial
This mixed-methods study aims to examine the impact of exposure to online medical misinformation on medication adherence, treatment decision-making, and healthcare-seeking behavior among patients with chronic diseases. The study targets patients with hypertension, diabetes mellitus, and dyslipidemia and evaluates how misinformation influences real-world health behaviors. Quantitative and qualitative data will be collected concurrently to provide a comprehensive understanding of misinformation-related health risks.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults ≥ 18 years
Disease duration ≥ 6 months
Social media use at least once weekly
Able to provide informed consent
Disqualifiers
Severe cognitive or psychiatric disorders
Trial population
Adult patients with chronic diseases attending outpatient clinics, who actively use social media and are exposed to online medical information.
Trial design
Other
Cross-sectional
Treatments tested in this trial
None (observational)
Other interventionNone (observational)
Treatment groups
Trial outcomes
Primary outcomes
Medication Adherence (MARS-5 Score)
Description: Measures adherence to prescribed medications
Secondary outcomes
Susceptibility to Medical Misinformation (OMISS Score)
Measures verification behavior toward online medical information
Treatment Decision Changes (OHIU-CD Subscale)
Measures changes in treatment decisions influenced by online information
Healthcare-Seeking Behavior Score
Qualitative Themes of Misinformation Impact
Sponsors and contacts
Click on the lead sponsor to view all of their trials.